| Title | Author(s) | Issue date | ???itemlist.??? |
| Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women | Athyros, V. G.; Ganotakis, E.; Kolovou, G. D.; Nicolaou, V.; Achimastos, A.; Bilianou, E.; Alexandrides, T.; Karagiannis, A.; Paletas, K.; Liberopoulos, E. N.; Tziomalos, K.; Petridis, D.; Kakafika, A.; Elisaf, M. S.; Mikhailidis, D. P. | 24-Nov-2015 | - |
| Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study | Athyros, V. G.; Karagiannis, A.; Ganotakis, E. S.; Paletas, K.; Nicolaou, V.; Bacharoudis, G.; Tziomalos, K.; Alexandrides, T.; Liberopoulos, E. N.; Mikhailidis, D. P. | 24-Nov-2015 | - |
| Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort | Athyros, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Papageorgiou, A. A.; Ganotakis, E. S.; Tziomalos, K.; Kakafika, A. I.; Karagiannis, A.; Lambropoulos, S.; Elisaf, M. S. | 24-Nov-2015 | - |
| Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental? | Katsiki, N.; Tziomalos, K.; Chatzizisis, Y.; Elisaf, M. S.; Hatzitolios, A. I. | 24-Nov-2015 | - |
| Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study | Athyros, V. G.; Mikhailidis, D. P.; Didangelos, T. P.; Giouleme, O. I.; Liberopoulos, E. N.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Burroughs, A. K.; Elisaf, M. S. | 24-Nov-2015 | - |
| Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study | Athyros, V. G.; Mikhailidis, D. P.; Liberopoulos, E. N.; Kakafika, A. I.; Karagiannis, A.; Papageorgiou, A. A.; Tziomalos, K.; Ganotakis, E. S.; Elisaf, M. S. | 24-Nov-2015 | - |
| Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels | Athyros, V. G.; Mikhailidis, D. P.; Kakafika, A. I.; Karagiannis, A.; Hatzitolios, A.; Tziomalos, K.; Ganotakis, E. S.; Liberopoulos, E. N.; Elisaf, M. S. | 24-Nov-2015 | - |
| Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome: A Post Hoc ATTEMPT Analysis | Athyros, V. G.; Elisaf, M. S.; Alexandrides, T.; Achimastos, A.; Ganotakis, E.; Bilianou, E.; Karagiannis, A.; Liberopoulos, E. N.; Tziomalos, K.; Mikhailidis, D. P. | 24-Nov-2015 | - |
| The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal? | Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.; Kakafika, A. I.; Tziomalos, K.; Liberopoulos, E. N.; Florentin, M.; Elisaf, M. S. | 24-Nov-2015 | - |
| Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study | Athyros, V. G.; Giouleme, O.; Ganotakis, E. S.; Elisaf, M. S.; Tziomalos, K.; Vassiliadis, T.; Liberopoulos, E. N.; Theocharidou, E.; Karagiannis, A.; Mikhailidis, D. P. | 24-Nov-2015 | - |
| Should atenolol still be recommended as first-line therapy for primary hypertension? | Karagiannis, A.; Athyros, V. G.; Papageorgiou, A.; Tziomalos, K.; Elisaf, M. S. | 24-Nov-2015 | - |
| Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? | Athyros, V. G.; Tziomalos, K.; Daskalopoulos, G. N.; Karagiannis, A.; Mikhailidis, D. P. | 24-Nov-2015 | - |
| Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients | Athyros, V. G.; Kakafika, A. I.; Papageorgiou, A. A.; Pagourelias, E. D.; Savvatianos, S. D.; Elisaf, M. S.; Karagiannis, A.; Tziomalos, K.; Mikhailidis, D. P. | 24-Nov-2015 | - |
| Targeting vascular risk in patients with metabolic syndrome but without diabetes | Athyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Peletidou, A.; Kleta, D.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Elisaf, M. S. | 24-Nov-2015 | - |
